$3.690
+0.103 (+2.79%)收盘时
- 最高
- 3.830
- 开盘
- 3.710
- 成交量加权均价
- 3.72
- 成交量
- 10.60K
- 市值
- 2.90M
- 最低
- 3.650
- 成交额
- 39.48K
- 企业价值/息税折旧摊销前利润(TTM)
- -0.90
Healthcare Triangle, Inc. is a healthcare information technology company. The Company is focused on advancing innovative, industry-transforming solutions in the areas of cloud services, data science, professional and managed services for the Healthcare and Life Sciences industry. Its Software Services segment provides strategic advisory, implementation, and development services. Its Managed Services and Support segment includes post-implementation support and cloud hosting. Its Customer Engagement Services provide customer search, marketing, telemarketing and customer-support services to financial institutions, insurance companies and intermediaries, and other customers. The Company's proprietary platforms include CloudEz, DataEz, Readabl.AI, Ziloy, and Ezovion. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical, and life sciences, biotech companies, and medical device manufacturers.
AI 分析 of Healthcare Triangle Inc (HCTI)
卖出HCTI is not a good buy right now due to its extremely low RSI of 15.487, indicating it is oversold, and a staggering year-to-date change of -99.50%, which reflects severe declines in value. The company has also reported consistent net losses, with a net income of -6198000 in Q1 2026 and -4415000 in Q2 2026, which raises concerns about its financial health. The main risk is the potential for further declines in stock price, given its current position at 0.0% of the 52-week range, indicating it is trading at its lowest point.
估值指标
事件时间线
资讯
7.511-02PRnewswireHealthcare Triangle Targets Indonesia's Healthcare Market Expansion
7.510-22PRnewswireHealthcare Triangle Signs Multi-Year Agreements for EHR and Cybersecurity
8.510-22PRnewswireHealthcare Triangle Announces 1-for-20 Reverse Stock Split
7.510-20PRnewswireHCTI Secures Six Client Engagements Worth $1.34M
7.509-30PRnewswireHCTI Signs MOU for North American Joint Venture with AI World
HCTI 常见问题 —— 由 Alphio AI 解答
Healthcare Triangle, Inc. is a healthcare information technology company. The Company is focused on advancing innovative, industry-transforming solutions in the areas of cloud services, data science, professional and managed services for the Healthcare and Life Sciences industry. Its Software Services segment provides strategic advisory, implementation, and development services. Its Managed Services and Support segment includes post-implementation support and cloud hosting. Its Customer Engagement Services provide customer search, marketing, telemarketing and customer-support services to financial institutions, insurance companies and intermediaries, and other customers. The Company's proprietary platforms include CloudEz, DataEz, Readabl.AI, Ziloy, and Ezovion. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical, and life sciences, biotech companies, and medical device manufacturers. It operates in the Technology sector (SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN industry).
HCTI is not a good buy right now due to its extremely low RSI of 15.487, indicating it is oversold, and a staggering year-to-date change of -99.50%, which reflects severe declines in value. The company has also reported consistent net losses, with a net income of -6198000 in Q1 2026 and -4415000 in Q2 2026, which raises concerns about its financial health. The main risk is the potential for further declines in stock price, given its current position at 0.0% of the 52-week range, indicating it is trading at its lowest point.
社区
更多 ↗暂无帖子
注册或登录后参与讨论相关文章
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。